FDA Drug Shortage Database
Pentostatin (Nipent) shortage
The FDA Drug Shortage Database lists 1 of 1 pentostatin presentations as limited or unavailable (updated August 27, 2026); the first entry was posted on August 27, 2026.
- No generic listed
- In shortage
- Boxed warning
Check it at the source: the FDA Drug Shortage Database.
Which strengths are short?
| Strength | Limited or unavailable now | Listed now, available | Resolved or discontinued |
|---|---|---|---|
| 10mg injection | 1 | 0 | 0 |
Which presentations are listed?
Limited or unavailable now (1)
| Presentation | Company | Status and dates | Availability and reason given |
|---|---|---|---|
| Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01) | Hospira, Inc., a Pfizer Company | Current posted August 27, 2026, updated August 27, 2026 | Unavailable; Other |
Source: FDA Drug Shortage Database via openFDA, read October 8, 2026
Are medicines for the same conditions short too?
Medicines whose labels share an indication with this one, and their own shortage status; listed as records, not substitutes.
| Medicine | Shared indication | Shortage | Generic labelers | Pharmacy cost |
|---|---|---|---|---|
| Nelarabine | Leukemia, lymphoma and myeloma | No current entry | 12 labelers | n/a |
| Clofarabine | Leukemia, lymphoma and myeloma | No current entry | 9 labelers | n/a |
| Fludarabine | Leukemia, lymphoma and myeloma | No current entry | 6 labelers | n/a |
| Cytarabine | Leukemia, lymphoma and myeloma | No current entry | 5 labelers | n/a |
| Cytarabine and daunorubicin | Leukemia, lymphoma and myeloma | No current entry | none listed | n/a |
| Cyclophosphamide | Leukemia, lymphoma and myeloma | No current entry | 19 labelers | $1.67 per capsule 50 mg capsule |
| Doxorubicin | Leukemia, lymphoma and myeloma | No current entry | 16 labelers | n/a |
| Bortezomib | Leukemia, lymphoma and myeloma | No current entry | 22 labelers | n/a |
| Arsenic trioxide | Leukemia, lymphoma and myeloma | A presentation being discontinued | 16 labelers | n/a |
| Bendamustine | Leukemia, lymphoma and myeloma | A presentation being discontinued | 4 labelers | n/a |
| Idarubicin | Leukemia, lymphoma and myeloma | No current entry | 2 labelers | n/a |
| Melphalan | Leukemia, lymphoma and myeloma | A presentation being discontinued | 13 labelers | n/a |
Source: FDA drug labels, FDA Drug Shortage Database, NDC Directory, CMS NADAC of October 7, 2026 (FDA files October 8, 2026)
What next?
- Every shortage now
- medicines by presentations in shortage